Completed NA INTERVENTIONAL 2-arm NCT01397279

Assessment of Liver Glucose Metabolism in Diabetic Subjects (CLAVA)

Sponsor: German Diabetes Center

Conditions Newly Diagnosed Type 2 Diabetes (During the Last 12 Months)

Interventions hyperinsulinemic euglycemic clamp intravenous glucose tolerance test

Updated 7 times since 2017 Last updated: Jun 2, 2023 Started: Jul 31, 2011 Primary completion: Dec 31, 2013 Completion: Dec 31, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01397279, this NA trial focuses on Newly Diagnosed Type 2 Diabetes (During the Last 12 Months) and remains completed. Sponsored by German Diabetes Center, it has been updated 7 times since 2011, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jul 2023 — Jul 2024 [monthly]

Completed NA
Jan 2021 — Jul 2023 [monthly]

Completed NA
Dec 2020 — Jan 2021 [monthly]

Completed NA

Status: Unknown Status → Completed

▶ Show 2 earlier versions

Jun 2018 — Dec 2020 [monthly]

Unknown Status NA
Jan 2017 — Jun 2018 [monthly]

Unknown Status NA

First recorded

Jul 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

German Diabetes Center

Data source: German Diabetes Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Düsseldorf, Germany